Analyst Ratings for Cyteir Therapeutics (CYT)
CYT Rating Summary
CYT Price Target Summary
- Highest: $3.00 (BofA Securities)
- Lowest: $3.00 (BofA Securities)
- Average: $3.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.00 (-0.7%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$3.00 (-0.7%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2024 | BofA Securities | Tazeen Ahmad | Downgrade | Underperform (Neutral) |
3.00 (2.00) |
3.06 (3.02) |
-1.31% | Details |
| 2/3/2023 | Morgan Stanley | Jeffrey Hung | Downgrade | Underweight (Equalweight) |
2.00 (4.00) |
1.57 (3.02) |
92.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
